Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft model.
Autor: | YORIKO YAMASHITA-KASHIMA1, SEI SHU1, KEIGO YOROZU1, YOICHIRO MORIYA1, NAOKI HARADA1 haradanok@chugai-pharm.co.jp |
---|---|
Zdroj: | Oncology Letters. Oct2017, Vol. 14 Issue 4, p4197-4205. 9p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |